Revised forecast
Fiscal year ending September 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Although profitability in the Legacy Industry DX business improved, the company continued and expanded aggressive upfront investment in the stablecoin business and tokenized deposit-related business within the Financial DX business. The company expects to continue investing in the Financial DX business in the fiscal year ending September 2027, resulting in a further widening of losses.
No extraordinary losses in the fiscal year ended September 2026 (total extraordinary losses: none; impairment losses: none). For reference, the company recorded impairment losses of ¥108.444 million in the fiscal year ended September 2025.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥17,702 million |
| Operating profit | Not disclosed → ¥-1,500 million |
| Ordinary income | Not disclosed → ¥-1,533 million |
| Profit attributable to owners of the parent | Not disclosed → ¥-1,658 million |
| Net income per share | Not disclosed → ¥-143.78 / sen |
| Fiscal Period Covered | Fiscal year ending September 2027 |
| Period Covered | Full year |
| Previous-period results | Revenue: ¥16,780 million; operating loss: ¥887 million; ordinary loss: ¥950 million; net loss attributable to owners of the parent: ¥1,194 million; net loss per share: -¥103.75 |
| Reason for the revision | Although profitability in the Legacy Industry DX business improved, the company continued and expanded aggressive upfront investment in the stablecoin business and tokenized deposit-related business within the Financial DX business. The company expects to continue investing in the Financial DX business in the fiscal year ending September 2027, resulting in a further widening of losses. |
| Details and amount of extraordinary loss | No extraordinary losses in the fiscal year ended September 2026 (total extraordinary losses: none; impairment losses: none). For reference, the company recorded impairment losses of ¥108.444 million in the fiscal year ended September 2025. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Profitability in the Legacy Industry DX business improved, but the company continued and expanded aggressive upfront investment in the stablecoin business and tokenized deposit-related business within the Financial DX business. The company plans to continue investing in the Financial DX business and other areas in the fiscal year ending September 2027.